0001144204-12-004226.txt : 20120126
0001144204-12-004226.hdr.sgml : 20120126
20120126181237
ACCESSION NUMBER: 0001144204-12-004226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120124
FILED AS OF DATE: 20120126
DATE AS OF CHANGE: 20120126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACYCLICS INC
CENTRAL INDEX KEY: 0000949699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943148201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
BUSINESS PHONE: 408 774 0330
MAIL ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAKER JULIAN
CENTRAL INDEX KEY: 0001087939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 12548692
MAIL ADDRESS:
STREET 1: BAKER BROTHERS ADVISORS
STREET 2: 667 MADISON AVENUE, 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAKER FELIX
CENTRAL INDEX KEY: 0001087940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 12548690
MAIL ADDRESS:
STREET 1: BAKER BROTHERS ADVISORS
STREET 2: 667 MADISON AVENUE, 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baker Biotech Capital (GP), LLC
CENTRAL INDEX KEY: 0001244389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 12548691
BUSINESS ADDRESS:
STREET 1: 667 MADISON AVE
STREET 2: 21ST FLOOR,
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-339-5600
MAIL ADDRESS:
STREET 1: 667 MADISON AVE
STREET 2: 21ST FLOOR,
CITY: NEW YORK
STATE: NY
ZIP: 10065
FORMER NAME:
FORMER CONFORMED NAME: BAKER BIOTECH CAPITAL GP LLC
DATE OF NAME CHANGE: 20030619
4
1
form447668_20120126061224-.xml
X0304
4
2012-01-24
0
0000949699
PHARMACYCLICS INC
PCYC
0001244389
Baker Biotech Capital (GP), LLC
667 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
US 10065
0
0
1
0
0001087940
BAKER FELIX
667 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
US 10065
0
0
1
0
0001087939
BAKER JULIAN
667 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
US 10065
0
0
1
0
Common Stock
2012-01-24
4
P
0
7926
17.8569
A
329144
I
Through Partnership
Common Stock
2012-01-24
4
P
0
14629
18.007
A
343773
I
Through Partnership
Common Stock
2012-01-25
4
P
0
18547
18.5473
A
362320
I
Through Partnership
Common Stock
2012-01-25
4
P
0
3018
18.4325
A
365338
I
Through Partnership
Common Stock
2012-01-26
4
P
0
28966
17.9507
A
394304
I
Through Partnership
Common Stock
2012-01-26
4
P
0
12907
17.8928
A
407211
I
Through Partnership
In addition to Baker Biotech Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group of such shareholders. (Continued in footnote 2).
However, the Reporting Persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
Represents securities owned directly by 667, L.P., the sole general partner of which is Baker Biotech Capital, L.P., a limited partnership the sole general partner of which is Baker Biotech Capital (GP),LLC. Julian C. Baker and Felix J. Baker are the controlling members of Baker Biotech Capital (GP), LLC.
/s/ Julian C. Baker, as Managing Member of Baker Biotech Capital (GP), LLC
2012-01-26
/s/ Julian C. Baker
2012-01-26
/s/ Felix J. Baker
2012-01-26